Corporate presentation

DBV, a revolution in immunotherapy

News

DBV Technologies Reports December 31, 2016 Cash Position

Documentation

20-F Form 2015

Video : The Epicutaneous Immunotherapy Company

Investor Relations

Phone : +33 1 55 42 78 78
Fax : +33 1 43 26 10 83